Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
3 hedge funds and large institutions have $2.06M invested in Motif Bio plc ADRs in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
72% less capital invested
Capital invested by funds: $7.29M → $2.06M (-$5.23M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$113K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$92K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9K |
MTFB Hedge Fund Activity: Q1 2019 in Review
3 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q1 2019, worth a combined $2.06M — down 72% from $7.29M a quarter earlier.
Fund positioning in MTFB was balanced in Q1 2019: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $113K. The largest seller was Jane Street, exiting entirely with an estimated $92K sold.
- 3 institutional investors held Motif Bio plc ADRs (MTFB) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $2.06M of Motif Bio plc ADRs stock for Q1 2019, down 72% quarter-over-quarter.
- 2 funds opened new Motif Bio plc ADRs positions in Q1 2019 and 2 closed out, a net change of 0 holders.
- The largest Motif Bio plc ADRs buyer in Q1 2019 was Virtu Financial, an estimated $113K added.
- The largest Motif Bio plc ADRs seller in Q1 2019 was Jane Street, an estimated $92K sold.
Based on aggregated 13F filings for Q1 2019.